Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 100
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
Fypryst Combo 268mg/241,2mg - V/DCP/14/0012 KRKA, d.d., Novo mesto, Slovēnija QP53AX65 large dogs Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Fipronil,S-Methoprene
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija
Date of authorisation/renewal: 27-Feb-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Sep-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Sep-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (22-Sep-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/14/0012-01 1 Polipropilēna pipete, 1 deva -
V/DCP/14/0012-02 3 Polipropilēna pipete, 1 deva -
V/DCP/14/0012-03 6 Polipropilēna pipete, 1 deva -
V/DCP/14/0012-04 10 Polipropilēna pipete, 1 deva -
Aurizon - V/NRP/03/1574 Vetoquinol S.A., Francija QS02CA06 dogs Vairāk

Medicinal product information

Pharmaceutical form: ear drops, suspension
International name (active substance): Marbofloxacin, Clotrimasolum, Dexamethasone acetate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Vetoquinol S.A., Francija
Date of authorisation/renewal: 18-Aug-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (29-Dec-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (29-Dec-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (29-Dec-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/03/1574-01 1 Pudelīte, 10 ml -
V/NRP/03/1574-02 1 Pudelīte, 20 ml -
V/NRP/03/1574-03 1 Pudelīte, 30 ml -
Pergocoat 0.25 mg V/DCP/25/0071 Alfasan Nederland BV, Nīderlande QN04BC02 horses Vairāk

Medicinal product information

Pharmaceutical form: film-coated tablets
International name (active substance): Pergolide mesylate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande;Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 20-Nov-2025
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Nov-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Nov-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (20-Nov-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/25/0071-01 1 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0071-02 3 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0071-03 6 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0071-04 9 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0071-05 10 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0071-06 12 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0071-07 16 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/25/0071-08 24 PVH/PE/PVDH-Al blisteris, 10 tablete -
Doxycare 40 mg V/DCP/19/0069 Ecuphar NV, Beļģija QJ01AA02 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Doxycycline (as Doxycycline hyclate)
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-May-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-May-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-May-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/19/0069-01 40 mg 1 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0069-02 40 mg 2 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0069-03 40 mg 3 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0069-04 40 mg 4 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0069-05 40 mg 5 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0069-06 40 mg 6 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0069-07 40 mg 7 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0069-08 40 mg 8 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0069-09 40 mg 9 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0069-10 40 mg 10 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0069-11 40 mg 25 Al/OPA/Al/PVH blisteris, 10 tablete -
Doxycare 200 mg V/DCP/19/0070 Ecuphar NV, Beļģija QJ01AA02 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Doxycycline (as Doxycycline hyclate)
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-May-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-May-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-May-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/19/0070-01 200 mg 1 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0070-02 200 mg 2 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0070-03 200 mg 3 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0070-04 200 mg 4 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0070-05 200 mg 5 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0070-06 200 mg 6 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0070-07 200 mg 7 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0070-08 200 mg 8 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0070-09 200 mg 9 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0070-10 200 mg 10 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/19/0070-11 200 mg 25 Al/OPA/Al/PVH blisteris, 10 tablete -
Pimocard 2.5 mg V/MRP/15/0061 Eurovet Animal Health B.V., Nīderlande QC01CE90 dogs Vairāk

Medicinal product information

Pharmaceutical form: flavoured tablets
International name (active substance): Pimobendan
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Dales Pharmaceuticals Ltd., Lielbritānija;Lelypharma B.V., Nīderlande;GENERA Inc., Horvātija
Date of authorisation/renewal: 31-Jul-2017
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [DOCX] 260122LI (26-Jan-2022)
Labelling text: [PDF] 280717M (31-Jul-2017)
Summary of product characteristics: [PDF] 280717ZA (31-Jul-2017)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/15/0061-01 2,5 mg 2 PVH/PE/PVAc blisters, 10 tablete -
V/MRP/15/0061-02 2,5 mg 5 PVH/PE/PVAc blisters, 10 tablete -
V/MRP/15/0061-03 2,5 mg 10 PVH/PE/PVAc blisters, 10 tablete -
V/MRP/15/0061-04 2,5 mg 25 PVH/PE/PVAc blisters, 10 tablete -
V/MRP/15/0061-05 2,5 mg 2 Al/Al blisteris, 10 tablete -
V/MRP/15/0061-06 2,5 mg 5 Al/Al blisteris, 10 tablete -
V/MRP/15/0061-07 2,5 mg 10 Al/Al blisteris, 10 tablete -
V/MRP/15/0061-08 2,5 mg 25 Al/Al blisteris, 10 tablete -
Vetmulin 125 mg/ml V/DCP/19/0001 Huvepharma NV, Beļģija QJ01XQ01 pigs; chickens Vairāk

Medicinal product information

Pharmaceutical form: solution for oral use
International name (active substance): Tiamulin hydrogen fumarate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Biovet Joint Stock Company., Bulgārija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (26-Feb-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (26-Feb-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (26-Feb-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/19/0001-01 1 ABPE pudele, 1 l -
V/DCP/19/0001-02 1 ABPE pudele, 5 l -
Noromectin Duo - V/DCP/13/0034 Norbrook Laboratories (Ireland) Limited, Īrija QP54AA51 horses Vairāk

Medicinal product information

Pharmaceutical form: paste for oral use
International name (active substance): Ivermectin, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Norbrook Laboratories Limited, Lielbritānija;Norbrook Manufacturing Limited, Īrija
Date of authorisation/renewal: 31-Oct-2018
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Apr-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Apr-2025)
Summary of product characteristics: [PDF] Zāļu_informācija_ZA_M_LI (08-Apr-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/13/0034-01 1 Pilnšļirce, 7,49 g -
V/DCP/13/0034-02 2 Pilnšļirce, 7,49 g -
V/DCP/13/0034-03 12 Pilnšļirce, 7,49 g -
V/DCP/13/0034-04 40 Pilnšļirce, 7,49 g -
V/DCP/13/0034-05 48 Pilnšļirce, 7,49 g -
V/DCP/13/0034-06 50 Pilnšļirce, 7,49 g -
Nobivac Rabies - V/NRP/93/0040 Intervet International B.V., Nīderlande QI07AA02 ferrets; cattle; sheep; goats; horses; dogs; cats; foxes Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Inactivated rabies virus strain Pasteur RIV
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Intervet International Booxmer, Nīderlande
Date of authorisation/renewal: 22-Sep-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (15-Oct-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (15-Oct-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (15-Oct-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/93/0040-01 10 Flakons, 1 deva -
V/NRP/93/0040-02 10 Flakons, 10 deva -
Octollar 1.25 g + 0.56 g - V/SRP/26/0008 Elanco GmbH, Vācija QP53AC55 dogs < 8 kg; cats Vairāk

Medicinal product information

Pharmaceutical form: medicated collar
International name (active substance): Imidacloprid, Flumethrin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KVP Pharma + Veterinar Produkte GmbH, Vācija
Date of authorisation/renewal: 23-Feb-2026
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: SRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Feb-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Feb-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (23-Feb-2026)

Products

ID Strength Package size Primary packaging Labelling
V/SRP/26/0008-01 1 Paciņa, 1 deva -
V/SRP/26/0008-02 2 Paciņa, 1 deva -
V/SRP/26/0008-03 12 Paciņa, 1 deva -
Octollar 4.50 g + 2.03 g - V/SRP/26/0009 Elanco GmbH, Vācija QP53AC55 dogs > 8 kg Vairāk

Medicinal product information

Pharmaceutical form: medicated collar
International name (active substance): Imidacloprid, Flumethrin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KVP Pharma + Veterinar Produkte GmbH, Vācija
Date of authorisation/renewal: 23-Feb-2026
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: SRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Feb-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Feb-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (23-Feb-2026)

Products

ID Strength Package size Primary packaging Labelling
V/SRP/26/0009-01 1 Paciņa, 1 deva -
V/SRP/26/0009-02 2 Paciņa, 1 deva -
V/SRP/26/0009-03 12 Paciņa, 1 deva -
Lozenord 5 mg/ml V/SRP/26/0011 Accord Healthcare B.V., Nīderlande QM01AC06 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Meloxicam
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Fundacio Privada Dau, Spānija
Date of authorisation/renewal: 24-Feb-2026
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: SRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Feb-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Feb-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (24-Feb-2026)

Products

ID Strength Package size Primary packaging Labelling
V/SRP/26/0011-01 1 Stikla flakons, 10 ml -
Ketamin 10% 100 mg/ml V/NRP/02/1507 Alivira Animal Health Limited;, Īrija QN01AX03 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Ketamine hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release LABORATORIOS KARIZOO, S.A., Spānija
Date of authorisation/renewal: 15-Jul-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (29-Dec-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (29-Dec-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (23-Mar-2026)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/02/1507-01 100 mg/ml 10 Stikla flakons, 10 ml -
V/NRP/02/1507-02 100 mg/ml 10 Stikla flakons, 25 ml -
Apravet 552 IU/mg V/DCP/18/0045 Huvepharma NV, Beļģija QA07AA92 pigs; rabbits; calves; chickens Vairāk

Medicinal product information

Pharmaceutical form: Powder for use in drinking water/milk
International name (active substance): Apramycin sulfate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Biovet Joint Stock Company., Bulgārija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Jul-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Jul-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (23-Jul-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/18/0045-01 1 ABPE pudele, 90,58 g -
V/DCP/18/0045-02 25 PE/AL/PP paciņa, 1,81 g -
V/DCP/18/0045-03 50 PE/AL/PP paciņa, 1,81 g -
V/DCP/18/0045-04 1 Maiss, 1811,6 g -
V/DCP/18/0045-05 1 PE/AL/PP paciņa, 1,81 g -
Enrocat flavour 25 mg/ml V/DCP/20/0016 Industrial Veterinaria, S.A., Spānija QJ01MA90 cats Vairāk

Medicinal product information

Pharmaceutical form: suspension for oral use
International name (active substance): Enrofloxacin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Labiana Life Sciences S.A., Spānija;aniMedica GmbH, Vācija;Industrial Veterinaria, S.A., Spānija;aniMedica Herstellungs GmbH, Vācija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Mar-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Mar-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (03-Mar-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/20/0016-01 25 mg/ml 1 ABPE pudele, 8,5 ml -
DINOPROST Bioveta 5 mg/ml V/DCP/26/0012 Bioveta a.s., Čehija QG02AD01 cattle; pigs; horses Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Dinoproston tromethamine
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 03-Mar-2026
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Mar-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Mar-2026)
Summary of product characteristics: [DOC] Zāļu_informācija_ZA_M_LI (03-Mar-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/26/0012-01 1 Stikla flakons, 10 ml -
V/DCP/26/0012-02 1 Stikla flakons, 50 ml -
Ketiva 150 mg/ml V/DCP/26/0013 VetViva Richter GmbH , Austrija QM01AE03 cattle; pigs; horses Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Ketoprofen
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release VetViva Richter GmbH , Austrija
Date of authorisation/renewal: 03-Mar-2026
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Mar-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Mar-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (03-Mar-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/26/0013-01 1 Stikla flakons, 100 ml -
V/DCP/26/0013-02 10 Stikla flakons, 100 ml -
Novamune - V/DCP/18/0053 Ceva-Phylaxia Veterinary Biologicals Co. Ltd., Ungārija QI01AD09 chickens Vairāk

Medicinal product information

Pharmaceutical form: concentrate and solvent for suspension for injection
International name (active substance): Live attenuated Infectious Bursal Disease virus, serotype 1, strain SYZA26
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Ceva-Phylaxia Veterinary Biologicals Co. Ltd., Ungārija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Jun-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Jun-2025)
Summary of product characteristics: [PDF] Zāļu_informācija_ZA_M_LI (03-Jun-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/18/0053-01 1 Stikla ampula (2ml), 500 deva -
V/DCP/18/0053-02 1 Stikla ampula (2ml), 1000 deva -
V/DCP/18/0053-03 1 Stikla ampula (5ml), 2000 deva -
V/DCP/18/0053-04 1 Stikla ampula (5ml), 500 deva -
V/DCP/18/0053-05 1 Stikla ampula (5ml), 1000 deva -
V/DCP/18/0053-06 1 Maisiņš, 200 ml -
V/DCP/18/0053-07 1 Maisiņš, 400 ml -
V/DCP/18/0053-08 1 Maisiņš, 800 ml -
V/DCP/18/0053-09 1 Maisiņš, 1000 ml -
V/DCP/18/0053-10 1 Maisiņš, 1200 ml -
V/DCP/18/0053-11 1 Maisiņš, 1600 ml -
Thiafeline 2.5 mg V/DCP/13/0025 Le Vet Beheer B.V., Nīderlande QH03BB02 cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Thiamazol
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lindopharm GmbH, Vācija;Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 27-Feb-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Apr-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Feb-2019)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (22-Apr-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/13/0025-01 2,5 mg 1 PVH/Al blisteris (necaurspīdīgs), 30 tablete -
V/DCP/13/0025-02 2,5 mg 2 PVH/Al blisteris (necaurspīdīgs), 30 tablete -
V/DCP/13/0025-03 2,5 mg 4 PVH/Al blisteris (necaurspīdīgs), 30 tablete -
V/DCP/13/0025-04 2,5 mg 5 PVH/Al blisteris (necaurspīdīgs), 30 tablete -
V/DCP/13/0025-05 2,5 mg 10 PVH/Al blisteris (necaurspīdīgs), 30 tablete -
Synulox RTU - V/NRP/02/1476 Zoetis Belgium S.A., Beļģija QJ01CR02 cattle; pigs; dogs; cats

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Amoxicillin trihydrate, Potassium clavulanate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Haupt Pharma Latina S.R.L., Itālija
Date of authorisation/renewal: 07-Dec-2012
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (29-May-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (29-May-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (30-May-2023)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/02/1476-01 1 Flakons, 100 ml -
V/NRP/02/1476-02 1 Flakons, 40 ml -
V/NRP/02/1476-03 12 Flakons, 40 ml -
V/NRP/02/1476-04 6 Flakons, 100 ml [PDF] [PDF]

3082 records

© Food and veterinary service · 2026 Cookies policy